Literature DB >> 682122

The binding of [3H]diazepam to rat brain homogenates.

C R Mackerer, R L Kochman, B A Bierschenk, S S Bremner.   

Abstract

A technique is described for the measurement of specific [3H]diazepam binding to subcellular fractions of rat brain. Binding occurred in fresh or hypotonically shocked, frozen and thawed preparations; was independent of the buffer used; and was concentrated in the synaptosomal fraction. The total binding capacity of crude brain homogenate was entirely recovered in the particulate fractions (P1, P2 and P3). Binding was saturable and reached 34 pmol/g of tissue; half-maximal binding (KD) occurred at 3.2 nM. Hill and Scatchard analysis indicated that the binding was noncooperative and to a single class of sites. Binding was time dependent and reversible; the bimolecular association constant (K1) was 1.13 . 10(6) sec-1 M-1 and the first order dissociation constant (K-1) was 2.69 . 10(-3) sec-1. Binding was highest in cerebral cortex, hippocampus and cerebellum; intermediate in midbrain, hypothalamus, corpus striatum and medulla oblongata/pons; and lowest in spinal cord. Benzodiazepines inhibited binding of [3H]diazepam in a manner correlated with pharmacological activity in vivo, and binding was not inhibited by non-benzodiazepine anxiolytics, muscle relaxants, anticonvulsants or by strychnine and glycine. Distribution of [3H]diazepam binding in several regions of the rat central nervous system correlated with Na+-independent binding of gamma-aminobutyric acid in the same regions. The results may be in accord with the possible involvement of gamma-aminobutyric acid in the mechanism of action of the benzodiazepines but provide no support for a mechanism based on the interaction of benzodiazepines with central glycine receptors.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 682122

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Benzodiazepine receptors in the brain as affected by different experimental stresses: the changes are small and not undirectional.

Authors:  C Braestrup; M Nielsen; E B Nielsen; M Lyon
Journal:  Psychopharmacology (Berl)       Date:  1979-11       Impact factor: 4.530

2.  Does the tissue concentration in receptor binding studies change the affinity of the labelled ligand?

Authors:  K Ensing; R A De Zeeuw
Journal:  Pharm Weekbl Sci       Date:  1984-12-14

Review 3.  Halopemide, a new psychotropic agent. Cerebral distribution and receptor interactions.

Authors:  A J Loonen; W Soudijn
Journal:  Pharm Weekbl Sci       Date:  1985-02-22

4.  Urinary and brain beta-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors.

Authors:  C Braestrup; M Nielsen; C E Olsen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

5.  Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics.

Authors:  Y Kiuchi; T Kobayashi; J Takeuchi; H Shimizu; H Ogata; M Toru
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

Review 6.  Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia.

Authors:  G E Pakes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

7.  Benzodiazepines that bind at peripheral sites inhibit cell proliferation.

Authors:  J K Wang; J I Morgan; S Spector
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

Review 8.  Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.

Authors:  G W Dawson; S G Jue; R N Brogden
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546

9.  The binding of [3H]-diazepam to guinea-pig ileal longitudinal muscle and the in vitro inhibition of contraction by benzodiazepines.

Authors:  J P Hullihan; S Spector; T Taniguchi; J K Wang
Journal:  Br J Pharmacol       Date:  1983-02       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.